AZD2066 Neuropathic Pain - Mechanical Hypersensitivity

Stopped early · Phase 2 · Has a placebo group

Conditions studied: Neuropathic Pain, Mechanical Hypersensitivity

In brief

The purpose of this study is to investigate if 28 days of treatment with AZD2066 compared to placebo can relieve the pain arising from the nervous system when the patients are touched by something that should not cause pain or have severe pain when they are touched by something that should only cause a little pain.

Key facts

Study ID
NCT00939094
Run by
AstraZeneca
People needed
87
Starts
2009-08-01
Expected to finish
2010-11-01
Last updated by the study team
2012-09-27

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.